0001567619-18-006486.txt : 20181115 0001567619-18-006486.hdr.sgml : 20181115 20181115174048 ACCESSION NUMBER: 0001567619-18-006486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181113 FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufmann Mark CENTRAL INDEX KEY: 0001611184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 181188166 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34175 ARDENWOOD BLVD, SUITE 100 CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 doc1.xml FORM 4 X0306 4 2018-11-13 0 0001437402 ARDELYX, INC. ARDX 0001611184 Kaufmann Mark C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 200 FREMONT CA 94555 0 1 0 0 Chief Financial Officer Common Stock 2018-11-13 4 S 0 6539 2.84 D 146489 D Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. This transaction was executed in multiple trades in prices ranging from $2.81 to $2.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Includes 1,642 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2018. /s/ Elizabeth Grammer, Attorney-in-Fact for Mark Kaufmann 2018-11-15